by John McMillan | Nov 13, 2026 | COVID-19
Dr. Philip McMillan, John McMillan A new preprint shows that naive human B cells are three times less likely to recognise the latest COVID variants than the original Wuhan strain. Surveillance dashboards, meanwhile, are reportedly quiet. The signal lies in the gap...
by John McMillan | Nov 6, 2026 | COVID-19
Dr. Philip McMillan, John McMillan Two young athletes died on 1 November. Each death has an explanation on the record, and each points to a question medicine has barely begun to study. On Sunday, 1 November, Rachel Apa was running her first New York City Marathon,...
by John McMillan | Oct 30, 2026 | COVID-19
Dr. Philip McMillan, John McMillan The switch fixes one of the strangest problems with mRNA vaccines and leaves a bigger one untouched. In late April 2026, Sanofi announced that it had beaten Moderna and Pfizer in a Swedish national tender. From the 2027/2028...
by John McMillan | Oct 23, 2026 | COVID-19
Dr. Philip McMillan, John McMillan The first head-to-head study of three mRNA vaccines in people finds the genetic cargo and its fatty packaging persisting far longer than the public was led to expect, much of it in pieces. For most of the pandemic, the reassurance...
by John McMillan | Oct 16, 2026 | COVID-19
Dr. Philip McMillan, John McMillan On paper, it should have worked. More than 17,000 adults aged 60 and over, every one of them with a past urinary tract infection, rolled up their sleeves in 20 countries for a vaccine designed to stop one of the most common causes...
by John McMillan | Oct 9, 2026 | COVID-19
Dr. Philip McMillan, John McMillan On a Friday in Siberia, a 28-year-old woman who worked at the Siberian Plague Institute died of pneumonia. Around 200 people were placed in quarantine. Reuters reported that no plague cases had been detected, and the origin of her...
Recent Comments